Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Atlassian Corporation PLC (TEAM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Atlassian Corporation PLC — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Atlassian Corporation PLC trades at $202 (market cap $51.81B). The key difference: Atlassian Corporation PLC is far larger — about 5.8× Kymera Therapeutics Inc. Common Stock's market cap, and Atlassian Corporation PLC is trading nearer its 52-week high, Kymera Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Atlassian Corporation PLC for 65 Days on average.
| KYMR | TEAM | |
|---|---|---|
Market Cap | $8.88B | $51.81B |
Volume | 1,028,790 | 2,082,521 |
Sector | Health | Technology |
52-Week High | $127.31 | $208.04 |
52-Week Low | $55.80 | $57.15 |
Typical Hold Time | 0 Days | 65 Days |
Enterprise Value | $8.27B | $51.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Atlassian (TEAM) trades at $208.04, up 0.14% with strong technical momentum as the stock approaches resistance near $212. The company shows robust revenue growth, improving from $2.8B in 2022 to $5.2B in 2025, though it remains unprofitable with a -0.82% net margin. Recent earnings beats and accelerating cloud migration, with AI adoption driving optimism among analysts who maintain a strong buy consensus.
TEAM presents a growth-focused opportunity with significant AI-driven expansion potential in its $140B addressable market. However, persistent losses, high valuation multiples (P/S 8.1, EV/EBITDA 244.15), and negative cash flow projections for 2026 pose risks. The stock's current price near consensus target suggests limited near-term upside without sustained profitability improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Atlassian Corporation PLC
Atlassian produces software that helps teams work together more efficiently and effectively. The company provides project planning and management software, collaboration tools, and IT help desk solutions. The company operates in four segments: subscriptions (term licenses and cloud agreements), maintenance (annual maintenance contracts that provide support and periodic updates and are generally attached to perpetual license sales), perpetual license (upfront sale for indefinite usage of the software), and other (training, strategic consulting, and revenue from the Atlassian Marketplace app store). Atlassian was founded in 2002 and is headquartered in Sydney.
Read more on TEAM →
